Phase I IIA Pediatric Study Indication TBD
Research payments
$166,736
Through program year 2022, $166,736 in research payments was reported against Phase I IIA Pediatric Study Indication TBD, across 40 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $79,189 | 5 |
| 2021 | Research | $87,547 | 35 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Theodore Nicolaides New York, NY Named on 4 payments
- Margaret Shatara Saint Louis, MO Named on 4 payments
- Elizabeth Sokol Chicago, IL Named on 3 payments
- Kieuhoa Vo San Francisco, CA Named on 3 payments
- Kevin Bielamowicz Little Rock, AR Named on 2 payments
- Tom Davidson Los Angeles, CA Named on 2 payments
- Lindsay Kilburn Washington, DC Named on 2 payments
- Margaret Macy Aurora, CO Named on 2 payments
- Ira Dunkel New York, NY Named on 2 payments
- Joanne Lagmay Gainesville, FL Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.